<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36580">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02630316</url>
  </required_header>
  <id_info>
    <org_study_id>RIN-PH-201</org_study_id>
    <nct_id>NCT02630316</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE</brief_title>
  <official_title>A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, randomized (1:1 inhaled treprostinil: placebo), double-blinded,
      placebo-controlled trial to evaluate the safety and efficacy of inhaled treprostinil in
      subjects with pre-capillary pulmonary hypertension (PH) associated with interstitial lung
      disease (ILD) including combined pulmonary fibrosis and emphysema (CPFE). The study will
      include about 314 patients at approximately 120 clinical trial centers. The treatment phase
      of the study will last approximately 16 weeks. Patients who complete all required
      assessments will also be eligible to enter an open-label, extension study (RIN-PH-202).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 6-minute Walk Distance (6MWD) Measured at Peak Exposure from Baseline to Week 16</measure>
    <time_frame>Baseline and Week 16</time_frame>
    <description>The intent of the 6MWD test is to evaluate exercise capacity associated with carrying out activities of daily living. Change in 6MWD from Baseline to Week 16, correlates with the current clinical standard for assessing patient functional status in the treatment of PH and is considered an objective measure of patient functional status. Subjects will be instructed to walk down a corridor at a comfortable speed as far as they can manage for six minutes. Distance &lt;500 meters suggests considerable exercise limitation; Distance 500-800 meters suggests moderate limitation; Distance &gt;800 meters (with no rests) suggests mild or no limitation. Peak exposure 6MWD will occur by conducting 6-minute walk test (6MWT) within 10 to 60 minutes after the most recent dose of study drug dose.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Peak 6-minute Walk Distance (6MWD) from Baseline to Week 12</measure>
    <time_frame>Baseline and Week 12</time_frame>
    <description>The intent of the 6MWD test is to evaluate exercise capacity associated with carrying out activities of daily living. Change in 6MWD from Baseline to Week 12, correlates with the current clinical standard for assessing patient functional status in the treatment of PH and is considered an objective measure of patient functional status. Subjects will be instructed to walk down a corridor at a comfortable speed as far as they can manage for six minutes. Distance &lt;500 meters suggests considerable exercise limitation; Distance 500-800 meters suggests moderate limitation; Distance &gt;800 meters (with no rests) suggests mild or no limitation. Peak exposure 6MWD will occur by conducting 6-minute walk test (6MWT) within 10 to 60 minutes after the most recent dose of study drug dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Trough 6-minute Walk Distance (6MWD) from Baseline to Week 15</measure>
    <time_frame>Baseline and Week 15</time_frame>
    <description>The intent of the 6MWD test is to evaluate exercise capacity associated with carrying out activities of daily living. Change in 6MWD from Baseline to Week 15, correlates with the current clinical standard for assessing patient functional status in the treatment of PH and is considered an objective measure of patient functional status. Subjects will be instructed to walk down a corridor at a comfortable speed as far as they can manage for six minutes. Distance &lt;500 meters suggests considerable exercise limitation; Distance 500-800 meters suggests moderate limitation; Distance &gt;800 meters (with no rests) suggests mild or no limitation. Trough exposure 6MWD will occur by conducting 6-minute walk test (6MWT) at least four hours after the most recent study drug dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma concentration of N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) from Baseline to Week 16</measure>
    <time_frame>Baseline and Week 16</time_frame>
    <description>The N-terminal pro-BNP (NT-proBNP) serum concentration is a useful biomarker associated with changes in right heart morphology and function. NT-proBNP serum concentration will be assessed to compare the severity of heart failure at Baseline and Week 16. Blood for NT-proBNP assessment must be drawn prior to conducting the 6-minute walk test (6MWT).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">314</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <condition>Interstitial Lung Disease</condition>
  <condition>Combined Pulmonary Fibrosis and Emphysema</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo inhaled using an ultrasonic nebulizer four times daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Inhaled Treprostinil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active Treprostinil for inhalation solution (0.6 mg/mL) delivered via an ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath. Inhaled four times daily and titrated up to a maximum of 12 breaths four times daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled Treprostinil</intervention_name>
    <description>Inhaled treprostinil (6 mcg/breath) administered four times daily</description>
    <arm_group_label>Active Inhaled Treprostinil</arm_group_label>
    <other_name>Tyvaso</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo administered four times daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject voluntarily gives informed consent to participate in the study.

          2. Males and females aged 18 years or older at the time of informed consent.

             a. Females of reproductive potential must be non-pregnant (as confirmed by a urine
             pregnancy test at screening) and non-lactating, and will: i. Either abstain from
             intercourse (when it is in line with their preferred and usual lifestyle), or ii. Use
             two medically acceptable, highly-effective forms of contraception for the duration of
             study, and at least 30 days after discontinuing study drug.

             b. Males with a partner of childbearing potential must use a condom for the duration
             of treatment and for at least 48 hours after discontinuing study drug.

          3. The subject has a confirmed diagnosis of WHO Group 3 PH based on CT imaging, which
             demonstrates evidence of diffuse parenchymal lung disease performed within 6 months
             prior to randomization. Subjects may have any form of ILD or CPFE.

          4. Subjects are required to have a right heart catheterization (RHC) within one year
             prior to randomization with the following documented parameters:

               1. Pulmonary vascular resistance (PVR) &gt; 3 Wood Units (WU) and

               2. A pulmonary capillary wedge pressure (PCWP) of &lt; 15 mmHg and and

               3. A mean pulmonary arterial pressure (mPAP) of ≥ 25 mmHg

          5. Baseline 6MWD ≥ 100 meters

          6. Subjects on a chronic medication for underlying lung disease (ie, pirfenidone,
             nintedanib, etc) must be on a stable and optimized dose for ≥ 30 days prior to
             randomization. Subjects receiving pirfenidone or nintedanib must have been receiving
             treatment for at least 90 days and on a stable dose for at least 30 days prior to
             randomization.

          7. In the opinion of the Investigator, the subject is able to communicate effectively
             with study personnel, and is considered reliable, willing and likely to be
             cooperative with protocol requirements, including attending all study visits.

          8. Subjects with connective tissue disease (CTD) must have a Baseline FVC of &lt; 70%.

        Exclusion criteria:

          1. The subject has a diagnosis of pulmonary arterial hypertension (PAH) or PH for
             reasons other than WHO Group 3 PH-ILD as outlined in inclusion criterion 3.

          2. The subject has shown intolerance or significant lack of efficacy to a prostacyclin
             or prostacyclin analogue that resulted in discontinuation or inability to effectively
             titrate that therapy.

          3. The subject has received any PAH approved therapy including: prostacyclin therapy
             (i.e., epoprostenol, treprostinil, iloprost, or beraprost; except for acute
             vasoreactivity testing), IP receptor agonist (selexipag), endothelin receptor
             antagonist (ERA), phosphodiesterase type 5 inhibitor (PDE-5I), or soluble guanylate
             cyclase (sGC) within 60 days of randomization.

          4. The subject has evidence of clinically significant left-sided heart disease as
             defined by:

               1. PCWP &gt; 15 mmHg

               2. Left ventricular ejection fraction &lt; 40%.

             Note: Subjects with abnormal left ventricular function attributable entirely to
             impaired left ventricular filling due to the effects of right ventricular overload
             (i.e., right ventricular hypertrophy and/or dilatation) will not be excluded.

          5. The subject is receiving &gt; 10 L/min of oxygen supplementation by any mode of delivery
             at rest at Baseline.

          6. Current use of any inhaled tobacco/marijuana products or significant history of drug
             abuse at the time of informed consent.

          7. Exacerbation of underlying lung disease or active pulmonary or upper respiratory
             infection within 30 days of randomization.

          8. Initiation of pulmonary rehabilitation within 12 weeks prior to the randomization.

          9. In the opinion of the Investigator, the subject has any condition that would
             interfere with the interpretation of study assessments or has any disease or
             condition (ie, peripheral vascular disease, musculoskeletal disorder, morbid obesity)
             that would likely be the primary limit to ambulation (as opposed to PH).

         10. Use of any investigational drug/device, or participation in any investigational study
             with therapeutic intent within 30 days prior to randomization.

         11. Severe concomitant illness limiting life expectancy (&lt; 6 months).

         12. Acute pulmonary embolism within 90 days of randomization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole Leedom</last_name>
    <email>nleedom@unither.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hilary Mauney</last_name>
    <email>hmauney@unither.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Powell</last_name>
      <phone>205-975-9859</phone>
      <email>lcpowell@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Bourge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Pulmonary Specialists, Ltd.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monya Pierce</last_name>
      <phone>602-271-0832</phone>
      <email>monya-research@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jeremy Feldman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Palm</last_name>
      <phone>520-626-8034</phone>
      <email>staceypalm@email.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Franz Rischard, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco - Fresno</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Garcia</last_name>
      <phone>559-499-6637</phone>
      <email>sgarcia@fresno.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Vijay Balasubramanian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Pulmonary Medical Group</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mostafa Elsiah</last_name>
      <phone>951-373-5827</phone>
      <email>mostafa.ppmg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Heba Ismail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Suderow</last_name>
      <phone>916-734-1554</phone>
      <email>mlsuderow@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Roblee Allen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital - Cardiac and Vascular Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Abbott, RN, CCRP</last_name>
      <phone>303-724-7466</phone>
      <email>cheryl.abbott@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Todd Bull, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Egidio</last_name>
      <phone>303-270-2622</phone>
      <email>egidioc@njhealth.org</email>
    </contact>
    <investigator>
      <last_name>Amy Olson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Cooney</last_name>
      <phone>202-444-0895</phone>
      <email>Cooneym@gunet.georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Tunay Kuru, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Sleep, Allergy and Lung Institute</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33765</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Linden</last_name>
      <phone>727-210-4606</phone>
      <email>elinden@stfrancismed.com</email>
    </contact>
    <investigator>
      <last_name>Francis Averill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida College of Medicine, Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minal Patel</last_name>
      <phone>904-244-1106</phone>
      <email>Minal.patel@jax.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Vandana Seeram, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Kennedy</last_name>
      <email>kennedy.shannon@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Burger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miami VA Medical Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvana Cobian</last_name>
      <email>Silvana.Cobian@va.gov</email>
    </contact>
    <investigator>
      <last_name>Michael Campos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliana Mendes, MD</last_name>
    </contact>
    <contact_backup>
      <phone>305-243-2568</phone>
      <email>emendes@med.miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David De La Zerda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Florida Pulmonary Group, P.A.</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zarah Rodriguez</last_name>
      <phone>407-841-1100</phone>
      <phone_ext>107</phone_ext>
      <email>zrodriguez@cfpulmonary.com</email>
    </contact>
    <investigator>
      <last_name>Syed Mobin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Miami Heart Specialists</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jojie Calderin</last_name>
      <phone>305-999-3301</phone>
      <email>gcalderin@ampmrc.com</email>
    </contact>
    <investigator>
      <last_name>Javier Jimenez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norma Jean Barton</last_name>
      <phone>954-659-6213</phone>
      <email>bartonn2@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Franck Rahaghi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Emory Clinic</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Gillespie, RN</last_name>
    </contact>
    <contact_backup>
      <phone>404-712-8204</phone>
      <email>jane.gillespie@emory.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Micah Fisher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Travis, RN, BSN</last_name>
      <phone>312-695-2269</phone>
      <email>margaret.travis@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Hector Cajigas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Ostrower</last_name>
      <phone>312-355-5934</phone>
      <email>ostrower@uic.edu</email>
    </contact>
    <investigator>
      <last_name>Roberto Machado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Coslet</last_name>
    </contact>
    <contact_backup>
      <phone>773-864-5768</phone>
      <email>scoslet@medicine.bsd.uchicago.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Remzi Bag, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Shore</last_name>
      <phone>708-216-2027</phone>
      <email>jshore@luc.edu</email>
    </contact>
    <investigator>
      <last_name>James Gagermeier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IU Health Physicians Advanced Heart &amp; Lung Clinic</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Turk</last_name>
      <phone>317-962-3183</phone>
      <email>eturk@iuhealth.org</email>
    </contact>
    <investigator>
      <last_name>William Harvey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Heart and Vascular Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46250</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanna Greene-Nashold, RN</last_name>
      <phone>317-621-8629</phone>
      <email>jgnashold@ecommunity.com</email>
    </contact>
    <investigator>
      <last_name>Navneet Lather, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Group, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Margiotti</last_name>
      <phone>317-338-6151</phone>
      <email>ramargio@stvincent.org</email>
    </contact>
    <investigator>
      <last_name>Ashwin Ravichandran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mia Zou</last_name>
      <phone>913-588-7117</phone>
      <email>mzou@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Leslie Spikes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>April Butler</last_name>
    </contact>
    <contact_backup>
      <phone>859-218-6740</phone>
      <email>april.evans@uky.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ketan Buch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kentuckiana Pulmonary Associates</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha Royse, APRN</last_name>
      <phone>502-587-8000</phone>
      <email>roysenp@gmail.com</email>
    </contact>
    <investigator>
      <last_name>John McConnell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville Physicians Outpatient Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Hamlyn</last_name>
      <phone>502-852-8739</phone>
      <email>Joan.hamlyn@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Jimmy Shaun Smith, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana State University Health Sciences Center New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Lauto, RN</last_name>
      <phone>504-568-3451</phone>
      <email>plauto@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Lammi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane University</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Ditta</last_name>
      <phone>504-988-4040</phone>
      <email>sditta@tulane.edu</email>
    </contact>
    <investigator>
      <last_name>Shigeki Saito, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lioubov Poliakova</last_name>
      <phone>410-328-6885</phone>
      <email>lpoliako@medicine.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Gautam V. Ramani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Visnaw, RN</last_name>
      <phone>617-636-1334</phone>
      <email>Kvisnaw@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Nicholas Hill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Lawler, RN</last_name>
      <phone>617-525-9731</phone>
      <email>llawler@partners.org</email>
    </contact>
    <investigator>
      <last_name>Aaron B. Waxman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Day</last_name>
      <phone>313-916-1254</phone>
      <email>jday5@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Rana Awdish, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Medical Center</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Cope, RN</last_name>
      <phone>616-391-3869</phone>
      <email>molly.cope@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Reda Girgis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretchen Peichel</last_name>
      <phone>612-626-6237</phone>
      <email>gpeichel@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Thenappan Thenappan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Daley</last_name>
      <email>daley.shannon@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Hilary DuBrock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Miller</last_name>
      <email>amymiller@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Mark Yagan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Traci Nelson</last_name>
      <phone>402-559-7585</phone>
      <email>trnelson@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Austin Thompson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Butcher, PhD, BSN, RN</last_name>
      <phone>505-925-1160</phone>
      <email>BButcher@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Lana Melendres-Groves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Furqan Ilyas</last_name>
      <phone>518-262-1542</phone>
      <email>ilyasf@mail.amc.edu</email>
    </contact>
    <investigator>
      <last_name>Boris Medarov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Puja Chadha</last_name>
      <phone>718-780-5614</phone>
      <email>puc9004@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Ruth Minkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pulmonary Health Physicians, PC</name>
      <address>
        <city>Fayetteville</city>
        <state>New York</state>
        <zip>13066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Gabris, RN</last_name>
    </contact>
    <contact_backup>
      <phone>315-234-0816</phone>
      <email>Victoria.Gabris@CNYLungs.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sherif El Bayadi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sameer Verma, MD</last_name>
      <phone>516-465-5437</phone>
      <email>SVerma3@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Arunabh Talwar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICAHN School of Medicine - Mount Sinai Beth Israel</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anabela Barroso</last_name>
      <phone>212-844-8824</phone>
      <email>abarroso@CHPNET.ORG</email>
    </contact>
    <investigator>
      <last_name>Roxana Sulica, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewelina Wojtaszek</last_name>
    </contact>
    <contact_backup>
      <phone>917-501-5255</phone>
      <email>ewelina.wojtaszek@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>Radha Gopalan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dakota Buhrman</last_name>
      <phone>919-445-0353</phone>
      <email>dakota_buhrman@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Hubert James (Jimmy) Ford III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karla Kennedy, RN</last_name>
      <email>karla.kennedy@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Sudarshan Rajagopal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Carl and Edyth Lindner Research Center at The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Lawrence</last_name>
      <phone>513-585-1777</phone>
      <email>christine.lawrence@thechristhospital.com</email>
    </contact>
    <investigator>
      <last_name>Peter Engel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Health</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tammy Roads</last_name>
      <phone>513-558-2148</phone>
      <email>roadst@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Jean Elwing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Andrews</last_name>
      <email>mary.andrews@uhhospitals.org</email>
    </contact>
    <contact_backup>
      <phone>216-844-2386</phone>
    </contact_backup>
    <investigator>
      <last_name>Robert Schilz, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Oklahoma Health Sciences Center (OUHSC)</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Robertson</last_name>
      <phone>405-271-6173</phone>
      <email>jennifer-robertson@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Himanshu Bhardwaj, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lancaster General Health</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lou Anne Kruse, RN, BSN</last_name>
      <phone>717-544-1777</phone>
      <email>lakruse@LGHealth.org</email>
    </contact>
    <investigator>
      <last_name>Justin Roberts, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gayle Jones, RN</last_name>
      <phone>215-707-1041</phone>
      <email>Gayle.Jones@tuhs.temple.edu</email>
    </contact>
    <investigator>
      <last_name>Sheila Weaver, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Rossi, RN</last_name>
      <phone>412-359-3293</phone>
      <email>joan.rossi@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Amresh Raina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Swati Gulati</last_name>
      <phone>412-864-6371</phone>
      <email>gulatis2@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Risbano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AnMed Health Pulmonary and Sleep Medicine</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlesa Davis</last_name>
      <phone>864-512-8519</phone>
      <email>charlesa.davis2@anmedhealth.org</email>
    </contact>
    <investigator>
      <last_name>Abhijit Raval, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robyn Do</last_name>
      <phone>843-792-1221</phone>
      <email>dorobyn@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Rahul Argula, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Statcare Pulmonary Consultants</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krista Tibbs</last_name>
      <phone>865-934-2676</phone>
      <email>ktibbs@biomed-research.com</email>
    </contact>
    <investigator>
      <last_name>John Swisher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adetoun Sodimu</last_name>
      <phone>214-645-6439</phone>
      <email>Adetoun.Sodimu@UTSouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Sonja Bartolome, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Saulino, RN</last_name>
      <phone>713-441-7182</phone>
      <email>asaulino@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Adaani Frost, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michael E. DeBakey VA Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Perusich</last_name>
      <phone>713-794-7294</phone>
      <email>Sarah.Perusich@va.gov</email>
    </contact>
    <investigator>
      <last_name>Lavannya Pandit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Ostovar-Kermani</last_name>
      <phone>713-500-6851</phone>
      <email>Tiffany.G.OstovarKermani@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Bela Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Dib</last_name>
      <phone>210-415-1180</phone>
      <email>Dibo@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Deborah Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scott &amp; White Memorial Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Murdoch</last_name>
      <phone>254-724-7168</phone>
      <email>Lori.Murdoch@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>Peter Yau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont, Vermont Lung Center</name>
      <address>
        <city>Colchester</city>
        <state>Vermont</state>
        <zip>05446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Meehan</last_name>
      <phone>802-847-3627</phone>
      <email>Kathy.Meehan@uvmhealth.org</email>
    </contact>
    <investigator>
      <last_name>Maryellen Antkowiak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Cardiovascular Research Institute</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Bullivant</last_name>
      <phone>757-388-4024</phone>
      <email>MMBULLIV@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Michael Eggert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pulmonary Associates of Richmond</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose Sidell</last_name>
      <phone>804-288-5945</phone>
      <email>rsidell@paraccess.com</email>
    </contact>
    <investigator>
      <last_name>Shilpa Johri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin School of Medicine and Public Health</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Wollet</last_name>
      <phone>608-263-0524</phone>
      <email>ljwollet@medicine.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>James Runo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Boehm, RN</last_name>
      <phone>414-649-5664</phone>
      <email>linda.boehm@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Dianne Zwicke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>December 11, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Treprostinil</keyword>
  <keyword>PH</keyword>
  <keyword>ILD</keyword>
  <keyword>CPFE</keyword>
  <keyword>6 Minute Walk Test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Treprostinil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
